Efficacy of microvascular decompression on the vascular compression type of neurogenic hypertension: A meta-analysis - 24/11/20
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
| páginas | 7 |
| Iconografías | 2 |
| Vídeos | 0 |
| Otros | 0 |
Abstract |
Objective |
Neurogenic hypertension is a type of hypertension characterized by increased sympathetic activity. Vascular compression is one of the pathogenic mechanisms of neurogenic hypertension. The sample sizes of currently available studies on MVD in the treatment of hypertension are small, and the results are considerably different. Therefore, we conducted a meta-analysis of the previous literature to obtain the most realistic efficiency and analyzed the current situation of MVD as a treatment option of the vascular compression type of neurogenic hypertension.
Method |
We systematically searched and identified relevant studies published before July 2019 from PubMed and Embase. Six studies involving 162 participants were included into our final analysis.
Result |
The data showed that the effective rate of MVD was 70.1% (95% CI: 0.602–0.801). The most common offending vessel was PICA (29.9%), followed by VA/BA (23.9%) and VA/BA plus PICA (12.7%). Complications were mostly related to the VII, VIII, IX, and/or X cranial nerve dysfunction.
Conclusion |
MVD as a treatment option of the vascular compression type of neurogenic hypertension is effective and safe. In spite of this conclusion, more prospective studies are needed to confirm it. On the other hand, a diagnostic method with higher sensitivity and specificity is necessary.
El texto completo de este artículo está disponible en PDF.Keywords : Hypertension, Neurogenic, Microvascular decompression, Vascular compression
Esquema
| ☆ | No portion of this paper has been presented previously. |
Vol 176 - N° 10
P. 763-769 - décembre 2020 Regresar al número
Artículo precedente
- The Marquise de Dampierre identified at last, the first described clinical case of Gilles de la Tourette syndrome
- O. Walusinski, J.-C. Féray
- Deep brain stimulation programming in Parkinson's disease: Introduction of current issues and perspectives
- M. Aubignat, M. Lefranc, M. Tir, P. Krystkowiak
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?